Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Current status of thrombolytics-the need for better, especially safer, agents. Thromb Res 2008;122 Suppl 3:S1-2

Date

08/20/2008

Pubmed ID

18710780

DOI

10.1016/j.thromres.2008.06.008

Scopus ID

2-s2.0-50849135517 (requires institutional sign-in at Scopus site)   6 Citations

Abstract

Clot dissolution using enzymes from the human fibrinolytic system has long been a goal of physicians and scientists. While recent focus has been on activators of the fibrinolytic system, new data support the use of plasmin itself. This supplement reviews the role of plasmin in fibrinolysis and locally administered plasmin as a safe and effective therapeutic.

Author List

White GC 2nd

Author

Gilbert C. White MD Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Fibrinolytic Agents
Humans
Thrombosis